SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-015031
Filing Date
2022-05-20
Accepted
2022-05-20 16:08:40
Documents
1
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165307729475114.html 4  
1 FORM 4 wf-form4_165307729475114.xml 4 6074
  Complete submission text file 0001628280-22-015031.txt   7421
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 BC V8Z7X8
Business Address
Jayne David R.W. (Reporting) CIK: 0001838242 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 22947647